HIC
NVCR icon

Hartline Investment Corp’s NovoCure NVCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-316,331
Closed -$13.1M 111
2023
Q2
$13.1M Buy
316,331
+11,430
+4% +$474K 2.24% 12
2023
Q1
$18.3M Buy
304,901
+419
+0.1% +$25.2K 3.66% 7
2022
Q4
$22.3M Buy
+304,482
New +$22.3M 5.08% 4
2022
Q3
Sell
-335,191
Closed -$58M 197
2022
Q2
$58M Buy
335,191
+32,997
+11% +$5.71M 8.32% 2
2022
Q1
$67M Sell
302,194
-15,915
-5% -$3.53M 8.47% 2
2021
Q4
$23.9M Buy
318,109
+11,986
+4% +$900K 3.27% 9
2021
Q3
$35.6M Buy
306,123
+3,929
+1% +$456K 4.95% 4
2021
Q2
$67M Sell
302,194
-23,612
-7% -$5.24M 8.47% 2
2021
Q1
$43.1M Sell
325,806
-9,385
-3% -$1.24M 6.55% 2
2020
Q4
$58M Sell
335,191
-395
-0.1% -$68.4K 8.32% 2
2020
Q3
$37.4M Sell
335,586
-1,031
-0.3% -$115K 6.31% 3
2020
Q2
$20M Buy
336,617
+6,454
+2% +$383K 4.18% 6
2020
Q1
$22.2M Sell
330,163
-509
-0.2% -$34.3K 5.55% 3
2019
Q4
$27.9M Buy
330,672
+216
+0.1% +$18.2K 5.97% 3
2019
Q3
$24.7M Sell
330,456
-5,129
-2% -$384K 5.94% 2
2019
Q2
$21.2M Sell
335,585
-6,870
-2% -$434K 5.07% 2
2019
Q1
$16.5M Sell
342,455
-62,611
-15% -$3.02M 4.31% 3
2018
Q4
$13.6M Sell
405,066
-4,540
-1% -$152K 4.13% 3
2018
Q3
$21.5M Sell
409,606
-5,323
-1% -$279K 5.02% 2
2018
Q2
$13M Buy
414,929
+10,877
+3% +$340K 3.5% 4
2018
Q1
$8.81M Buy
404,052
+13,579
+3% +$296K 2.42% 9
2017
Q4
$7.89M Buy
390,473
+22,306
+6% +$451K 2.18% 9
2017
Q3
$7.31M Sell
368,167
-2,168
-0.6% -$43K 2.21% 9
2017
Q2
$6.41M Buy
370,335
+188,774
+104% +$3.27M 2.04% 12
2017
Q1
$1.47M Sell
181,561
-14,287
-7% -$116K 0.47% 54
2016
Q4
$1.54M Buy
195,848
+54,907
+39% +$431K 0.54% 50
2016
Q3
$1.2M Buy
140,941
+57,751
+69% +$493K 0.43% 55
2016
Q2
$971K Sell
83,190
-400
-0.5% -$4.67K 0.35% 57
2016
Q1
$1.21M Buy
83,590
+32,450
+63% +$470K 0.44% 49
2015
Q4
$1.14M Buy
+51,140
New +$1.14M 0.43% 52